Haleon plc
HLN
Pozycja w akcjach
#13780
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
Cena akcji
$5.01
Ostatnia synchronizacja: 2026-10-21
Kapitalizacja rynkowa
$440.22M
Zmiana (1 dzień)
-2.22%
Zmiana (1 rok)
6.27%
Kraj
GB
Handel Haleon plc (HLN)
Kategoria
Healthcare
Historia ceny akcji dla Haleon plc (HLN)
Najwyższa cena zamknięcia: $4.68 dnia 2026-10-01
Najniższa cena zamknięcia: $3.48 dnia 2022-07-01
Najniższa cena zamknięcia: $3.48 dnia 2022-07-01
Historia cen akcji firmy Haleon plc od 2022 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | -0.76% |
| 2025 | 2.79% |
| 2024 | 16.19% |
| 2023 | 13.23% |
| 2022 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.32 | 42.64% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $19.19 | -0.09% |
IN
|
